OUR PRODUCTS

MOBILE APPS

GENERAL INFO

TBPH

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Theravance Biopharma (TBPH) Earnings Date & Reports

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

TBPH is expected to report earnings to fall 112.96% to -14 cents per share on November 05

Theravance Biopharma TBPH Stock Earnings Reports

Q3'25

Est.

$-0.14

Q2'25

Beat

by $0.41

Q1'25

Missed

by $0.05

Q4'24

Missed

by $0.11

Q3'24

Missed

by $0.03

The last earnings report on August 12 showed earnings per share of $1.08, beating the estimate of 67 cents. With 301.77K shares outstanding, the current market capitalization sits at 662.25M.

View a ticker or compare two or three

Compare

TBPH

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TBPH
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TBPH showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of small molecule pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

Ugland House, South Church Street

Phone

+1 650 808-6000

Employees

Web

https://www.theravance.com